Article Information
History
- January 25, 2022.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Evan A Elko1,
- Georgia A Nelson2,
- Heather L Mead2,
- Erin J Kelley2,
- Virginia Le Verche3,
- Angelo A Cardoso3,
- Jennifer L Ely2,
- Annalee S Boyle2,
- Alejandra Piña1,
- Sierra N Henson2,
- Fatima Rahee2,
- Paul S Keim1,
- Kimberly R Celona1,
- Jinhee Yi1,
- Erik W Settles1,
- George C Yu4,
- Sheldon R Morris5,
- John A Zaia3,
- Jason T Ladner1 and
- John A Altin2,*
- 1The Pathogen and Microbiome Institute, Northern Arizona University, Flagstaff, AZ, USA
- 2The Translational Genomics Research Institute (TGen), Phoenix and Flagstaff, AZ, USA
- 3Center for Gene Therapy, Department of Hematology and Hematopoietic Cell Transplantation, City of Hope National Medical Center, Duarte, California, CA, USA
- 4George C Yu, MD, Inc., Camarillo, CA
- 5University of California San Diego CIRM Alpha Stem Cell Clinic, La Jolla, CA
- ↵*Correspondence: jaltin{at}tgen.org
Posted January 25, 2022.
COVID-19 vaccination recruits and matures cross-reactive antibodies to conserved epitopes in endemic coronavirus Spike proteins
